I agree. Here's his response:
Solazyme (SZYM): It doesn't have a great balance sheet and it doesn't make a lot of money, said Cramer. Don't buy.
Although, Cramer is smart and what he reports are truly facts but that is a passing glimpse of a 2 hour movie.
Where is our long lost friend? Funny how he disappears when the stock appreciates. Interested in how these 2 conferences pan out and get the word out to many more potential customers.
AT, that's an interesting point I didn't think about GS today. Although you can't deny that it was best day on the DOW this year and the bias was on the upside for every stock. I own way too many stocks getting close to retirement and SZYM was my worst performer. Go figure. But the last 5 minutes caught my eye with the highest 5 minute volume of the day and even the average volume is high in the last 5 days which is over 2M today's volume was 120,000 over that too.
If SZYM closed down in a positive DOW not sure how well it will do in a selloff looming tomorrow. Putin is living in the 17th century. If he stands down, life will go on but that looks like wishful thinking right now.
SZYM has always given more chances to buy @ cheaper levels for whatever the reasons are. A down turn today was predictable but the close on the other hand is still in doubt. if it closes lower than the open investors are still holding out for confirmation of Moema if it closes above the open then SZYM may be finally getting to the holy grail discarding the speculative and unproven model cast.
Tough to take that after our earnings they are up again today more than we are (%) even after their big move yesterday.
Yeah I was in KIOR for awhile too but gave up on lack of follow thru. SZYM has been unwavering today which is so surprising to hold steady all day with huge volume. Very odd. Speculation stocks should always be a small portion of anyone's portfolio but I agree that SZYM is slowing proving beyond a spec stock.
Speaking of takeoff, have you seen BIOF today? Wish I owned that. I think they are mostly ethanol though.
Feb 27 (Reuters) - Solazyme Inc :
* Cowen and Company raises target price to $17 from $14; rating outperform
Sentiment: Strong Buy
Are you still here & are you kidding? Man, you are truly disturbed and must have a man crush on our fearless leader!
Big Picture is what I'm looking at too not just for making green ($$$$) but the environmental footprint is truly hard to grasp how transcending this company can be. The story is only in its infancy and there are many others in similar ventures and where it all unfolds is anyone's guess. Let's hope we play a really big part of aiding in a better future for our children. Oh & yeah making money in the process...
Sentiment: Strong Buy
Well we got the volume we've all been asking for but the price is kinda funny seeing that its roughly the exact same price as the close of biz yesterday. Equal amount of buyers & sellers before earnings. Most daytraders will never buy b4 earnings and take on that risk so its mostly institutionals setting up their bets before cc and a the smaller percentage of dummies like me buying more - lol.
at, you have done a lot of homework on the board :) Your post is quite accurate. We often wonder on 1 hand how the whole world hasn't noticed or has misunderstood SZYM while many, many articles from our dear friends @ Seeking Alpha & The Motley Fool have barraged us on mostly how great SZYM is. But on either side of the coin, the only thing that truly moves SZYM is SZYM which will be on full display tomorrow @ 4:30 PM. My gut even though our stock hasn't responded well in the last 2 weeks is that Moema will either be open or still on schedule by end of March & at least 1 additional partner will be added (IMHO). GL